[The role of surgery in the treatment of small cell lung cancer].
Small cell lung cancer (SCLC) is a biologically aggressive tumor with a low long-term survival rate. SCLC is highly responsive to chemotherapy and surgery has a very limited role in its treatment because the disease is usually widely disseminated at the diagnosis. Good results from surgery have been reported in the small subgroup of T1-2 N0 M0 patients. In N1 peripheral SCLC, surgery in combination with other treatments, can obtain fair results. Surgical treatment does not influence the prognosis in SCLC as stage III and IV.
Puma
F
F
Chirurgia Toracica, Ospedale Civile S. Maria, Terni, Università degli Studi, Perugia, Italy. francesopuma@tiscalinet.it
Urbani
M
M
Santoprete
S
S
Ricci
F
F
Sanguinetti
A
A
Vinci
D
D
Ottavi
P
P
Porcaro
G
G
Daddi
G
G
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging
D000970:Antineoplastic Agents
Ruolo della chirurgia nel trattamento del microcitoma polmonare.